Concepedia

Author

T. Izzo

Fatebenefratelli Hospital

Also Known As

T Izzo, T. Izzo, Tiziana Izzo

30

Publications

375

Citations

10

H-Index

21

Concepts

All Affiliations

Fatebenefratelli HospitalFederico II University HospitalIstituti di Ricovero e Cura a Carattere ScientificoCentro di Riferimento Oncologico della Basilicata
TI

About

T. Izzo is an author at Fatebenefratelli Hospital specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

67

2

Immunology

3

3

67

3

Health Sciences

2

2

24

4

Cell Biology

1

1

43

5

Cellular Therapies

1

1

13

T. Izzo

×

9

Publications

332

Citations

9

H-Index

YearCitations

High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders

Antonella Caivano, Ilaria Laurenzana, Luciana De Luca,

Tumor Biology

2015

183

HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b

Ilaria Lepore, Carmela Dell’Aversana, Maxim Pilyugin,

PLoS ONE

2013

43

Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis

Felicetto Ferrara, T. Izzo, Clelia Criscuolo,

Hematological Oncology

2010

24

Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission.

Felicetto Ferrara, Olimpia Finizio, T. Izzo,

PubMed

2010

17

Multivariable evaluation of maternal hemodynamic profile in pregnancy complicated by fetal growth restriction: prospective study

Daniela Di Martino, E. Ferrazzi, Massimo Garbin,

Ultrasound in Obstetrics and Gynecology

2018

16

Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan

Felicetto Ferrara, Salvatore Palmieri, Mariangela Pedata,

Hematological Oncology

2009

13

Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia

Felicetto Ferrara, Giuseppina Mele, Salvatore Palmieri,

Hematological Oncology

2009

13

Favorable Outcome in Patients with Acute Myelogenous Leukemia with the Nucleophosmin Gene Mutation Autografted after Conditioning with High-Dose Continuous Infusion of Idarubicin and Busulfan

Felicetto Ferrara, T. Izzo, Clelia Criscuolo,

Biology of Blood and Marrow Transplantation

2010

12

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: Feasibility, toxicity, and therapeutic results

Felicetto Ferrara, T. Izzo, Clelia Criscuolo,

American Journal of Hematology

2010

11

Page 1